| Literature DB >> 30140179 |
Ilona Gyuleva1, Jana Djounova1, Ivanka Rupova1.
Abstract
The aim of the present study is to assess the effects of low-dose occupational exposure on T helper response. One Hundred five employees working in Nuclear Power Plant, Kozloduy, Bulgaria and control group of 32 persons are included in this investigation. Flow cytometry measurements of T-cell populations and subpopulations and natural killer T cells are performed and levels of G, A, and M immunoglobulins and interleukin 2 (IL-2), IL-4, and interferon γ were determined. The data interpreted with regard to cumulative doses, length of service, and age. The results of the present study are not enough to outline a clear impact of occupational radiation exposure on T helper populations. Nevertheless, the observed even slight trends in some lymphocyte's populations and in cytokines profile give us the reason to assume a possibility of a gradual polarization of T helper 1 to T helper 2 immune response at dose range 100 to 200 mSv. The results of the present study indicate the need to perform a more detailed epidemiological survey including potential confounding and misclassifying factors and possible selection bias that could influence the results.Entities:
Keywords: NPP personnel; T-cell populations; immunoglobulins; interleukins; low-dose ionizing radiation
Year: 2018 PMID: 30140179 PMCID: PMC6096692 DOI: 10.1177/1559325818785564
Source DB: PubMed Journal: Dose Response ISSN: 1559-3258 Impact factor: 2.658
NPP “Kozloduy” Personnel Data According to Age, Length of Service, and Cumulative Dose.
| Personnel | Mean Age (SD), years | Mean Length of Service (SD), years | Mean Cumulative Dose (SD), mSv |
|---|---|---|---|
| Control: 32 persons | 45.6 (8) | 19.5 (7) | 0 |
| 1st group: 27 persons—0.1-25 mSv | 47.9 (6) | 21.5 (7) | 11.8 (9) |
| 2nd group: 31 persons—25.1-100 mSv | 48.1 (8) | 22.6 (8) | 53.2 (21) |
| 3rd group: 19 persons—100.1-200 mSv | 48.5 (3) | 25.2 (3) | 132.0 (30) |
| 4th group: 28 persons—above 200 mSv | 50.4 (6) | 27.7 (5) | 324.6 (89) |
Abbreviation: NPP, Nuclear Power Plant; SD, standard deviation.
Reference Values of Studied Interleukins.
| Parameters | Reference Values |
|---|---|
| IL-2 | 0-3 pg/mL |
| IFNγ | <15.6 pg/mL |
| IL-4 | 0-4 pg/mL |
Abbreviations: IL, interleukin; IFNγ, interferon γ.
Variation Analysis of Main Lymphocyte Populations According to Cumulative Dose.
| Parameters | Groups | X (SD), % | X (SD), cells/µL |
|---|---|---|---|
| B lymphocytes (CD19+) | Control | 10.25 (3.3) | 264.5 (131) |
| 1st: 0.1-25 mSv | 10.74 (3.9) | 242.0 (100) | |
| 2nd: 25.1-100 mSv | 10.22 (4.8) | 248.1 (132) | |
| 3rd: 100.1- 200 mSv | 9.16 (3.3) | 227.5 (97) | |
| 4th: Above 200 mSv | 10.17 (4.5) | 260.3 (135) | |
| Total T lymphocytes (CD3+) | Control | 72.97 (6.7) | 1842.8 (594) |
| 1st: 0.1-25 mSv | 70.63 (7.3) | 1603.0 (494) | |
| 2nd: 25.1-100 mSv | 74.87 (7.1) | 1806.8 (471) | |
| 3rd: 100.1-200 mSv | 72.78 (8.0) | 1816.2 (503) | |
| 4th: Above 200 mSv | 72.79 (8.9) | 1917.68 (789) | |
| Helper-inducer T lymphocytes (CD3+ CD4+) | Control | 43.4 (6.5) | 1094.28 (353) |
| 1st: 0.1-25 mSv | 42.67 (7.9) | 969.52 (338) | |
| 2nd: 25.1-100 mSv | 44.29 (6.9) | 1074.9 (299) | |
| 3rd: 100.1-200 mSv | 43.0 (10.4) | 1071.37 (404) | |
| 4th: Above 200 mSv | 44.45 (9.3) | 1168.48 (395 | |
| Cytotoxic-suppressor T lymphocytes (CD3+ CD8+) | Control | 28.47 (7.1) | 720.94 (288) |
| 1st: 0.1-25 mSv | 27.11 (8.6) | 614.52 (272) | |
| 2nd: 25.1-100 mSv | 31.19 (7.6) | 756.26 (260) | |
| 3rd: 100.1-200 mSv | 28.95 (10.1) | 727.95 (350) | |
| 4th: Above 200 mSv | 27.59 (7.8) | 694.41 (452) | |
| CD4+/CD8+ index | Control | 1.64 (0.6) | |
| 1st: 0.1-25 mSv | 1.77 (0.8) | ||
| 2nd: 25.1-100 mSv | 1.53 (0.5) | ||
| 3rd: 100.1-200 mSv | 1.69 (0.7) | ||
| 4th: Above 200 mSv | 1.79 (0.8) |
Abbreviations: SD, standard deviation; X, mean.
Variation Analysis of CD8+ CD28+ T Lymphocytes, NK, and NKT Cells According to Cumulative Dose.
| Parameters | Groups | X (SD), % | X (SD), cells/µL |
|---|---|---|---|
| CD8+CD28+ | Control | 14.8 (4) | 375.6 (148) |
| 1st: 0.1-25 mSv | 13.4 (4) | 305.4 (120) | |
| 2nd: 25.1-100 mSv | 14.2 (5) | 337.5 (123) | |
| 3rd: 100.1-200 mSv | 12.8 (3) | 314.5 (94) | |
| 4th: Above 200 mSv | 12.3 (5) | 336.9 (201) | |
| NK (CD3-CD16+CD56+) | Control | 16.1 (7) | 413.1 (234) |
| 1st: 0.1-25 mSv | 17.7 (8) | 418.2 (262) | |
| 2nd: 25.1-100 mSv | 14.1 (7) | 329 (153) | |
| 3rd: 100.1-200 mSv | 17.6 (8) | 426.2 (184) | |
| 4th: Above 200 mSv | 16.3 (8) | 433 (225) | |
| NKT (CD3+ CD16+ CD56+) | Control | 6.5 (5) | 174.5 (168) |
| 1st: 0.1-25 mSv | 9.3 (8) | 214.2 (185) | |
| 2nd: 25.1-100 mSv | 11.0 (7) | 266.6 (173) | |
| 3rd: 100.1-200 mSv | 10.6 (9) | 276.4 (273) | |
| 4th: Above 200 mSv | 8.7 (5) | 235.6 (174) |
Abbreviations: NK, natural killer; NKT cells, natural killer T cells; SD, standard deviation; X, mean.
Variation Analysis of T Helper Lymphocyte Subpopulations According to Cumulative Doses.
| Parameters | Groups | X (SD), % | X (SD), cells/µL |
|---|---|---|---|
| Naive | Control | 24.15 (19.6) | 280.2 (264) |
| CD4+ CDRA+ CD62L+ T lymphocytes | |||
| 1st: 0.1-25 mSv | 20.00 (17.4) | 201.7 (190) | |
| 2nd: 25.1-100 mSv | 16.58 (7.9) | 178.8 (106) | |
| 3rd: 100.1-200 mSv | 19.68 (17.1) | 213.9 (220) | |
| 4th: above 200 mSv | 16.28 (14.2) | 177.2 (154) | |
| Terminal effector | Control | 5.68 (9.6) | 52.7 (8.4) |
| CD4+ CDRA+ CD62L− T lymphocytes | |||
| 1st: 0.1-25 mSv | 5.79 (11.8) | 66.1 (142) | |
| 2nd: 25.1-100 mSv | 3.49 (7.1) | 45.7 (105) | |
| 3rd: 100.1-200 mSv | 5.62 (11.99) | 49.9 (84) | |
| 4th: Above 200 mSv | 1.29 (2.0) | 16.17 (19) | |
| Central memory | Control | 52.1 (22.6) | 631.35 (546) |
| CD4+ CDRO+ CD62L+ T lymphocytes | |||
| 1st: 0.1-25 mSv | 53.56 (21.5) |
| |
| 2nd: 25.1-100 mSv | 59.39 (13.8) | 631.48 (241) | |
| 3rd: 100.1-200 mSv | 49.26 (20.9) | 555.37 (329) | |
| 4th: Above 200 mSv | 62.38 (14.0) |
|
Abbreviations: SD, standard deviation; X, mean.
a Statistical confidence between the first and fourth group for central memory T cells (P = .012). There is significant statistical difference between the groups in boldface. It is described within the text.
Variation Analysis of Serum Levels of IgG, IgA, and IgM According to Cumulative Dose.
| Groups | IgG (g/L), X (SD) | IgA (g/L), X (SD) | IgM (g/L), X (SD) |
|---|---|---|---|
| Control | 10.81 (3.21) | 2.58 (1.23) | 1.54 (0.51) |
| 1st: 0.1-25 mSv | 10.51 (2.04) | 2.77 (0.91) | 1.26 (0.49) |
| 2nd: 25.1-100 mSv | 10.58 (2.34) | 2.66 (1.18) | 1.37 (0.55) |
| 3rd: 100.1-200 mSv | 10.26 (2.19) | 2.81 (0.94) | 1.36 (0.55) |
| 4th: Above 200 mSv | 10.72 (1.91) | 2.91 (0.97) | 1.19 (0.54) |
Abbreviations: Ig, immunoglobulins; SD, standard deviation; X, mean.
Frequency Analysis of Interleukins.
| Parameters | IL-2 (Out of Reference Values) | IL-4 (Out of Reference Values) | IFNγ (Out of Reference Values) |
|---|---|---|---|
| Control | 11.1% | – | 15.6% |
| 0-25 mSv | 11.1% | – | 33.3% |
| 25.1-100 mSv | 23.33% | – | 30% |
| 100.1-200 mSv | 11.1% | – | 27.78% |
| Above 200 mSv | 6.82% | – | 20.6% |
Abbreviations: IL, interleukin; IFNγ, interferon γ.
Variation Analysis of Plasma Levels of Interleukins According to Cumulative Dose.
| Groups | IL-2 (pg/mL), X (SD) | IL-4 (pg/mL), X (SD) | IFNγ (pg/mL), X (SD) |
|---|---|---|---|
| Control | 0.28 (1.2) | 0.26 (0.4) | 15.3 (4.9) |
| 1st: 0.1-25 mSv | 0.32 (1.1) | 0.18 (0.2) | 14.1 (5.9) |
| 2nd: 25.1-100 mSv | 1.04 (2.9) | 0.33 (0.6) | 13.4 (4.7) |
| 3rd: 100.1-200 mSv | 0.62 (1.9) |
| 14.8 (7.2) |
| 4th: Above 200 mSv | 0.69 (1.8) |
| 14.1 (5.6) |
Abbreviations: IL, interleukin; IFNγ, interferon γ; SD, standard deviation; X, mean.
a Statistical confidence between the third and fourth group for IL-4 (P < .05).